Search - tctmd.com

Displaying 241 - 260 of 1865

Sort: Relevancy | Date

News Conference News TCT 2022

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

Todd Neale

September 21, 2022

Presentation TCT 2022

TCT 31: Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using Drug-Eluting Stent

Presenter: Seung Hun Lee

September 19, 2022

Presentation TCT 2022

TCT 151: Dual Antiplatelet Therapy after Percutaneous Coronary Intervention for Left Main Coronary Artery Disease

Presenter: Sungsoo Cho

September 18, 2022

Presentation TCT 2022

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

Presenter: Mijin Kim

September 18, 2022

News Conference News TCT 2022

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

Todd Neale

September 18, 2022

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

Presentation TCT 2022

TCT 379: Single Antiplatelet Therapy Following Left Atrial Appendage Occlusion

Presenter: Anders Kramer

September 18, 2022

Presentation TCT 2022

TCT 4: Dual Antiplatelet Therapy for 1 Versus 3 Months in Women and Men at High Bleeding Risk Undergoing Drug-Eluting Stent Implantation

Presenter: Johny Nicolas

September 17, 2022

Presentation TCT 2022

TCT 2: Two-Year Outcomes in High Bleeding Risk Patients with Bifurcations after Percutaneous Coronary Intervention and One Month Dual Antiplatelet Therapy

Presenter: Ajay Kirtane

September 17, 2022

Presentation TCT 2022

TCT 18: De-Escalation of Antiplatelet Therapy in Stabilized Acute Myocardial Infarction Patients with High Ischemic Risk: Post hoc Analysis of TALOS-AMI Trial

Presenter: Donggyu Moon

September 17, 2022

Presentation TCT 2022

TCT 17: Single Antiplatelet Therapy Directly After Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndrome Patients: The OPTICA Pilot Study

Presenter: Niels van der Sangen

September 17, 2022

Presentation TCT 2022

TCT 15: Dual antiplatelet therapy-based de-escalation in acute coronary syndrome: An individual patient data meta-analysis

Presenter: Jeehoon Kang

September 17, 2022

Presentation TCT 2022

TCT 14: A 30-day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) Post PCI in Brazil and Japan : SYNERGY Stent with Prasugrel Monotherapy (10 or 3.75 mg )

Presenter: Yoshinobu Onuma

September 17, 2022

Presentation TCT 2022

TCT 13: Ticagrelor Monotherapy in Patients With Peripheral Artery Disease Undergoing PCI

Presenter: Alessandro Spirito

September 17, 2022

Presentation TCT 2022

TCT 29: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients with Diabetes: Results From the PTRG-DES Registry

Presenter: KI-HYUN JEON

September 17, 2022

Presentation TCT 2022

TCT 28: Pharmacodynamic response, early reperfusion and clinical outcomes to pre-hospital prasugrel administration in diabetic patients presenting with STEMI – A COMPARE CRUSH subanalysis

Presenter: Rosanne Vogel

September 17, 2022

Presentation TCT 2022

TCT 27: Ticagrelor versus Prasugrel in an All-Comer Patient Cohort undergoing Percutaneous Coronary Intervention

Presenter: Anoop Koshy

September 17, 2022

Presentation TCT 2022

TCT 26: Efficacy and Safety of Ticagrelor Compared to Clopidogrel in Elderly Patients With ST-Elevation Myocardial Infarction

Presenter: André Luz

September 17, 2022

Presentation TCT 2022

TCT 24: Ticagrelor versus Prasugrel in Acute Myocardial Infarction for East Asians

Presenter: Ji sung KIM

September 17, 2022

Presentation TCT 2022

TCT 23: Influence of the circadian clock on the pharmacodynamic effect of prasugrel in patients presenting with ST-segment elevation myocardial infarction – A COMPARE CRUSH subanalysis

Presenter: Rosanne Vogel

September 17, 2022

Advertisement

RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion

TCT 31: Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using Drug-Eluting Stent

TCT 151: Dual Antiplatelet Therapy after Percutaneous Coronary Intervention for Left Main Coronary Artery Disease

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

TCT 379: Single Antiplatelet Therapy Following Left Atrial Appendage Occlusion

TCT 4: Dual Antiplatelet Therapy for 1 Versus 3 Months in Women and Men at High Bleeding Risk Undergoing Drug-Eluting Stent Implantation

TCT 2: Two-Year Outcomes in High Bleeding Risk Patients with Bifurcations after Percutaneous Coronary Intervention and One Month Dual Antiplatelet Therapy

TCT 18: De-Escalation of Antiplatelet Therapy in Stabilized Acute Myocardial Infarction Patients with High Ischemic Risk: Post hoc Analysis of TALOS-AMI Trial

TCT 17: Single Antiplatelet Therapy Directly After Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndrome Patients: The OPTICA Pilot Study

TCT 15: Dual antiplatelet therapy-based de-escalation in acute coronary syndrome: An individual patient data meta-analysis

TCT 14: A 30-day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) Post PCI in Brazil and Japan : SYNERGY Stent with Prasugrel Monotherapy (10 or 3.75 mg )

TCT 13: Ticagrelor Monotherapy in Patients With Peripheral Artery Disease Undergoing PCI

TCT 29: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients with Diabetes: Results From the PTRG-DES Registry

TCT 28: Pharmacodynamic response, early reperfusion and clinical outcomes to pre-hospital prasugrel administration in diabetic patients presenting with STEMI – A COMPARE CRUSH subanalysis

TCT 27: Ticagrelor versus Prasugrel in an All-Comer Patient Cohort undergoing Percutaneous Coronary Intervention

TCT 26: Efficacy and Safety of Ticagrelor Compared to Clopidogrel in Elderly Patients With ST-Elevation Myocardial Infarction

TCT 24: Ticagrelor versus Prasugrel in Acute Myocardial Infarction for East Asians

TCT 23: Influence of the circadian clock on the pharmacodynamic effect of prasugrel in patients presenting with ST-segment elevation myocardial infarction – A COMPARE CRUSH subanalysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content